Denaturing gradient gel electrophoresis analysis of the hemochromatosis (HFE) gene: Impact of HFE gene mutations on the manifestation of porphyria cutanea tarda

Clinical Chemistry

Volumn 45, Issue 11, 1999, Pages 2025-2026

  Christiansen, Lene ^a   Bygum, Anette ^a   Thomsen, Kristian ^b   Brandrup, Fleming ^a   Hørder, Mogens ^a   Petersen, Niels E ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b BISPEBJERG HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL FEATURE; DENATURING GRADIENT GEL ELECTROPHORESIS; GENE FREQUENCY; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; HEMOCHROMATOSIS; HUMAN; MAJOR CLINICAL STUDY; PORPHYRIA CUTANEA TARDA; SEQUENCE ANALYSIS;

EID: 0032733817     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/45.11.2025     Document Type: Article

References (12)

1. 1. Kappas A, Sassa S, Gaibraith RA, Nordmann Y. The porphyrias. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic basis of inherited diseases, 7th ed. New York: McGraw-Hill, 1995;2103-60.
2. 2. Jackson HA, Whatley SD, Roberts AG, Morgan RR, Worwood M, Elder GH. Haemochromatosis gene mutations in familial and sporadic porphyria cutanea tarda [Abstract]. Blood 1999;90:604.
3. 3. Roberts AG, Whatley SD, Morgan RR, Worwood M, Elder GH. Increased frequency of the haemochromatosis Cys282Tyr mutation in sporadic porphyria cutanea tarda [see comments]. Lancet 1997;349:321-3.
4. 4. Bonkovsky HL, Poh-Fitzpatrick M, Pimstone N, Obando J, Di Bisceglie A, Tattrie C, et al. Porphyria cutanea tarda, hepatitis C, and HFE gene mutations in North America. Hepatology 1998;27:1661-9.
5. 5. Stuart KA, Busfield F, Jazwinska EC, Gibson P, Butterworth LA, Cooksley WG, et al. The C282Y mutation in the haemochromatosis gene (HFE) and hepatitis C virus infection are independent cofactors for porphyria cutanea tarda in Australian patients. J Hepatol 1998;28:404-9.
6. 6. Sampietro M, Piperno A, Lupica L, Arosio C, Vergani A, Corbetta N, et al. High prevalence of the His63Asp HFE mutation in Italian patients with porphyria cutanea tarda [see comments]. Hepatology 1998;27:181-4.
7. 7. D'Amato M, Macri A, Griso D, Biolcati G, Ameglio F. Are His63Asp or Cys282Tyr HFE mutations associated with porphyria cutanea tarda? Data of patients from central and southern Italy [Letter]. J Investig Dermatol 1998;111:1241-2.
8. 8. Mendez M, Sorkin L, Rossetti MV, Astrin KH, del C Batlle AM, Parera VE, et al. Familial porphyria cutanea tarda: characterization of seven novel uroporphyrinogen decarboxylase mutations and frequency of common hemochromatosis alleles. Am J Hum Genet 1998;63:1363-75.
9. 9. Douabin V, Moirand R, Jouanolle A, Brissot P, Le Gall J, Deugnier Y, David V. Polymorphisms in the HFE gene. Hum Hered 1999;49:21-6.
10. 10. Mura C, Raguenes O, Ferec C. HFE mutations analysis in 711 hemochromatosis probands: evidence for S65C implication in mild form of hemochromatosis. Blood 1999;93:2502-5.
11. 11. Steffensen R, Varming K, Jersild C. Determination of gene frequencies for two common haemochromatosis mutations in the Danish population by a novel polymerase chain reaction with sequence-specific primers. Tissue Antigens 1998;52:230-5.
12. 12. Nissen H, Petersen NE, Mustajoki S, Hansen TS, Mustajoki P, Kauppinen R, Hørder M. Diagnostic strategy, genetic diagnosis and identification of new mutations in intermittent porphyria by denaturing gradient gel electrophoresis. Hum Mutat 1997;9:122-30.